4-Chloro-8-methoxy-2-(trifluoromethyl)quinoline, 95.0%, 5g

Methyl 4-(bromomethyl)cyclohexanecarboxylate, 97.0%, 250mg

Colonne capillaire GC ROTI®Cap-1701, 25 m, 0,20 mm, 0,20 µm, 1 pièce(s)

N1,N4-Dihydroxyterephthalimidamide, 95.0%, 1g

1-(2-Hydroxyethyl)-2,2,6,6-tetramethylpiperidin-4-ol, 95.0%, 1g

1-Bromoperfluorohexane, 98.0%, 25g

4-{6-[6-(4-methylpiperazin-1-yl)-1H-1,3-benzodiazol-2-yl]-1H-1,3-benzodiazol-2-yl}phenol trihydrochloride, 98%, 100mg

Polydimethylsiloxanes, trimethylsiloxy terminated cSt 3.0, 100g

(4-((tert-Butoxycarbonyl)(methyl)amino)phenyl)boronic acid, 95.0%, 5g

N-Acetyl-D-phenylalanine>98.0%(HPLC)(T)1g

2-(2-Bromophenoxy)-n,n-dimethylacetamide, 95%, 250mg

2-(3,4-Dichlorophenyl)propan-2-amine, 98%, 250mg

N-Acetylglycine Ethyl Ester>98.0%(N)(GC)1g